UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000009204
Receipt number R000010805
Scientific Title Conversion from TIVA technique to Desflurane anesthesia for long duration neurosurgery; assessment of recovery parameters
Date of disclosure of the study information 2012/10/31
Last modified on 2017/08/08 17:25:22

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Conversion from TIVA technique to Desflurane anesthesia for long duration neurosurgery; assessment of recovery parameters

Acronym

Conversion from TIVA technique to Desflurane anesthesia for long duration neurosurgery; assessment of recovery parameters

Scientific Title

Conversion from TIVA technique to Desflurane anesthesia for long duration neurosurgery; assessment of recovery parameters

Scientific Title:Acronym

Conversion from TIVA technique to Desflurane anesthesia for long duration neurosurgery; assessment of recovery parameters

Region

Japan


Condition

Condition

Neurosurgery

Classification by specialty

Anesthesiology Neurosurgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The propose of this study is to evaluate the recovery parameters after conversion from TIVA technique to Desflurane anesthesia during long term neurosurgery procedures.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Duration time to the extubation after the end of anesthetics administration

Key secondary outcomes

Duration time to the eye opening after the end of anesthetics administration.
Time to recover the orientation after the end of anesthetics administration.
Preoperative and post operative Mini-Mental State Examination scores.
Duration of intensive care unit stay.
Intraoperative monitoring parameters after the switching form propofol to desflurane.


Base

Study type

Interventional


Study design

Basic design

Factorial

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Active

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is not considered as adjustment factor.

Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Control group patients will receive propofol till the end of surgery.

Interventions/Control_2

Study group patients will be switched to desflurane from propofol.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

65 years-old >=

Gender

Male and Female

Key inclusion criteria

Planned craniotomy patients.
ASA PS 1-3.
Estimated procedure time > 4 hr.

Key exclusion criteria

Malignant Hyperthermia.
History of the problem of previous anesthesia.
Contraindication for propofol and desflurane.
Preoperative cognitive disorder.
Required postoperative sedation.
Unstable vital or emergent cases.
Liver function(Child-Pugh classification of B and C) or renal function failure(CKD stage>3).

Target sample size

60


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Ozaki Makoto

Organization

Tokyo Women's Medical University

Division name

Department of Anesthesiology

Zip code


Address

8-1 Kawadacho Sinjuku-ku, Tokyo

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name

Organization

Tokyo Women's Medical University

Division name

Department of Anesthesiology

Zip code


Address

8-1 Kawadacho Sinjuku-ku, Tokyo

TEL


Homepage URL


Email



Sponsor or person

Institute

Tokyo Women's Medical University

Institute

Department

Personal name



Funding Source

Organization

Baxter

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東京女子医科大学病院(東京都)


Other administrative information

Date of disclosure of the study information

2012 Year 10 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2012 Year 10 Month 31 Day

Date of IRB


Anticipated trial start date

2012 Year 12 Month 01 Day

Last follow-up date


Date of closure to data entry

2017 Year 08 Month 08 Day

Date trial data considered complete

2017 Year 08 Month 08 Day

Date analysis concluded

2017 Year 08 Month 08 Day


Other

Other related information



Management information

Registered date

2012 Year 10 Month 28 Day

Last modified on

2017 Year 08 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000010805


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name